GE HealthCare Technologies revenue and financials
$64.77Change from previous close: −1.48%Absolute change: −$0.97
In the fiscal year ended December 2025, GE HealthCare Technologies reported revenue of $20.63B (+4.84% year over year). Net income was $2.08B, a net margin of 10.1%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +4.84%
- 2025 vs 2024
- Net income growth
- +4.57%
- 2025 vs 2024
- Net margin
- 10.1%
- 2024: 10.1%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | 1,987 | 1,951 | 2,101 | 2,113 | 1,607 |
| Depreciation and amortization | 578 | 580 | 610 | 633 | 625 |
| Capital expenditure | -482 | -401 | -387 | -310 | -248 |
| Investing cash flow | -1,047 | -914 | -558 | -398 | -1,761 |
| Financing cash flow | 618 | -572 | -478 | -822 | -263 |
| Dividends paid | -64.0 | -55.0 | -41.0 | 0.0 | 0.0 |
| Share repurchases | -242 | -93.0 | -33.0 | — | — |
| Debt issued | 2,735 | 995 | 2,006 | 8,207 | 5.0 |
| Debt repaid | -1,767 | -1,418 | -867 | -3.0 | -17.0 |
| Effect of exchange rates | 66.0 | -77.0 | -10.0 | -3.0 | -34.0 |
| Net change in cash | 1,622 | 387 | 1,055 | 890 | -451 |
| Free cash flow | 1,505 | 1,550 | 1,714 | 1,803 | 1,359 |
| Levered free cash flow | 1,449 | 1,877 | 2,521 | 1,867 | 748 |